whereas TNFalpha- and IL-6-stimulated activation are not antagonized.
Glia 40:109–120.
Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB. 2001.
TGF-beta increases retinal endothelial cell permeability by increasing
MMP-9: possible role of glial cells in endothelial barrier function.
Invest Ophthalmol Vis Sci 42:853–859.
Benveniste EN. 1994. Cytokine circuits in brain. Implications for
AIDS dementia complex. Res Publ Assoc Res Nerv Ment Dis 72:71–
88.
Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, Joag SV,
Narayan O, Cheney PD. 1999. Microglial activation and neurological
symptoms in the SIV model of NeuroAIDS: association of MHC-II and
MMP-9 expression with behavioral deficits and evoked potential
changes. Neurobiol Dis 6:486–498.
Bottner M, Krieglstein K, Unsicker K. 2000. The transforming growth
factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75:2227–2240.
Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Mullins ME, Lipton SA, Gendelman HE. 1995. Regulation of nitric oxide
synthase activity in human immunodeficiency virus type 1 (HIV-1)- infected monocytes: implications for HIV-associated neurological disease. J Exp Med 181:735–745.
Caglar K, Hakim RM, Ikizler TA. 2002. Approaches to the reversal of
malnutrition, inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev 60:378–387.
Chadderton T, Wilson C, Bewick M, Gluck S. 1997. Evaluation of three
rapid RNA extraction reagents: relevance for use in RT-PCR's and
measurement of low level gene expression in clinical samples. Cell Mol
Biol (Noisy-le-grand) 43:1227–1234.
Cheon H, Yu SJ, Yoo DH, Chae IJ, Song GG, Sohn J. 2002. Increased
expression of pro-inflammatory cytokines and metalloproteinase-1 by
TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal
individuals. Clin Exp Immunol 127:547–552.
Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA,
Bahr MJ, Cawston TE. 1997. Transcriptional activity of the human
tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts in- volves elements in the promoter, exon 1 and intron 1. Biochem J 324:
611–617.
Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN.
1999. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in
association with human immunodeficiency virus dementia. Ann Neurol
46:391–398.
Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C. 1998. HIV-infected subjects with the E4 allele for
APOE have excess dementia and peripheral neuropathy [see comments]. Nat Med 4:1182–1184.
Coyle-Rink J, Sweet T, Abraham S, Sawaya B, Batuman O, Khalili K,
Amini S. 2002. Interaction between TGFb signaling proteins and C/
EBP controls basal and Tat-mediated transcription of HIV-1 LTR in
astrocytes. Virology 299:240–247.
da Cunha A, Jefferson JA, Jackson RW, Vitkovic L. 1993. Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex.
J Neuroimmunol 42:71–85.
da Cunha A, Vitkovic L. 1992. Transforming growth factor-beta 1
(TGF-beta 1) expression and regulation in rat cortical astrocytes. J Neuroimmunol 36:157–169.
Dezzutti CS, Swords WE, Guenthner PC, Sasso DR, Wahl LM, Drummond AH, Newman GW, King CH, Quinn FD, Lal RB. 1999.
Involvement of matrix metalloproteinases in human immunodeficiency
virus type 1-induced replication by clinical Mycobacterium avium isolates. J Infect Dis 180:1142–1152.
Dhawan S, Wahl LM, Heredia A, Zhang Y, Epstein JS, Meltzer MS,
Hewlett IK. 1995. Interferon-gamma inhibits HIV-induced invasiveness
of monocytes. J Leukoc Biol 58:713–716.
